The effect of stress on cortisol, endocannabinoids and cognitive processing

Completed

• Conditions: HPA stress response; Mental Health - Studies of normal psychology, cognitive function and behaviour; Metabolic and Endocrine - Normal metabolism and endocrine development and function; Neurological - Studies of the normal brain and nervous system

• Registration Number: ACTRN12618000100291
• Lead Sponsor: niversity of Tasmania

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-01-23
• Study Completion: 2019-02-21
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 77

Inclusion Criteria

Participants will be healthy males and females in an age range of 18-40.

Exclusion Criteria

Participants will be excluded if they have a current psychiatric medication schedule or psychiatric diagnosis, current or history of regular illicit drug use, have an AUDIT score of 16 or above (indicative of heavy alcohol use), current tobacco use, history of head trauma, current pregnancy, epilepsy or seizures, sleep disorder, sleeping difficulties, skin sensitivities, existing cardiac or neurological condition, or uncorrected visual or auditory difficulties. In addition, given that we are measuring brain activity to verbal stimuli, participants will all have English as a first language. Participants will also be required to not have undergone the MAST stressor in the past.

Study & Design

• Study Type: Interventional
• Study Design: Not specified